TOP TIERMARKET NEWSWIRE
SEC Form 4 history

NEKTAR THERAPEUTICS (NKTR) insider trades

NEKTAR THERAPEUTICS (NKTR) insider trading activity (SEC Form 4). Over the trailing 90 days, NKTR insiders filed 0 purchases totalling $0 and 5 sales totalling $2.0M — net SELLING of $2.0M. Most recent filing: Jul 2, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$2.0M
Net (90d)
-$2.0M
net selling
Most recent
Jul 2, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 2, 2026Zalevsky JonathanChief R, D OfficerS Sale—$70.00$398Kfiling
Jun 18, 2026Robin Howard WPres, CEOS Sale—$60.75$1.2Mfiling
Jun 17, 2026Zalevsky JonathanChief R, D OfficerS Sale—$60.71$336Kfiling
May 21, 2026Robin Howard WPres, CEOS Sale—$65.51$29Kfiling
May 21, 2026Zalevsky JonathanChief R, D OfficerS Sale—$65.51$13Kfiling